Damora Therapeutics Names Jennifer Jarrett as President and CEO
- Mar 25
- 1 min read
Boston, MA, March 23, 2026 (Globe Newswire) -- Damora Therapeutics has appointed Jennifer Jarrett as president and chief executive officer, effective at the end of March. She brings extensive experience from prior leadership roles in biotech and investment banking. The company aims to leverage her expertise to advance its biologics pipeline for blood disorders.
Read full article here.






















Comments